NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/09/2020
Back to search
Official data from USPTO
ONCOPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
01/09/2020
Trademark type
Word
Nice classes
9
Filing date
05/30/2008
Registration date
12/22/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2020
Last transaction
01/09/2020
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Valencia, ES
Examiner
THOMAS, JULIE
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
INFORMATICA MEDICO; FARMACEUTICA, S.L.
INFORMATICA MEDICO; FARMACEUTICA, S.L.
Representatives
Garth E. Coviello Brown & Michaels, PC
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computer programs and software for use by health professionals for permitting real time access to patient information to physicianspharmacists and nurses and for scheduling office visits; Computer programs and software for use by health professionals for generating reports regarding biochemical and haematological control studies; Computer programs and software for use by health professionals for administering chemotherapy preparations and treatments to patients; Computer programs and software for use by health professionals for accurate patient treatment planning; Computer programs and software for use by health professionals for ensuring that each health professional in therapeutic chain complies with patient treatment protocol; Computer programs and software for use by health professionals for producing clinically valid data to support clinical decisions; Computer programs and software for use by health professionals in providing patients information regarding medication dosage and educational materials in the nature of tutorials in the field of medication side effects
Publications
History of USPTO decisions and trademark events.
38 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
01/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2020
ES71
TEAS SECTION 71 RECEIVED
11/24/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/22/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/12/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/09/2016
71AG
REGISTERED-SEC.71 ACCEPTED
01/08/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/07/2016
ES71
TEAS SECTION 71 RECEIVED
11/25/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/25/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/21/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/14/2010
FIMP
FINAL DISPOSITION PROCESSED
04/13/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/22/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
12/22/2009
PUBO
PUBLISHED FOR OPPOSITION
10/06/2009
NPUB
NOTICE OF PUBLICATION
09/16/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/03/2009
ALIE
ASSIGNED TO LIE
09/03/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/21/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/21/2009
CNFR
FINAL REFUSAL MAILED
06/29/2009
CNFR
FINAL REFUSAL WRITTEN
06/29/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2009
RFNT
REFUSAL PROCESSED BY IB
03/06/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/30/2009
RFRR
REFUSAL PROCESSED BY MPU
01/30/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/29/2009
CNRT
NON-FINAL ACTION WRITTEN
01/28/2009
MAFR
APPLICATION FILING RECEIPT MAILED
01/27/2009
DOCK
ASSIGNED TO EXAMINER
01/23/2009
NWAP
NEW APPLICATION ENTERED
01/23/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/22/2009
Continuous trademark protection
Get notified about every new filing that threatens ONCOPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.